Hudson Technologies (HDSN) Q3 2026 Earnings Call Transcript

Hudson Technologies reported Q3 2026 revenue down 20% year over year to $59.4 million as sales volume fell 9% and average selling prices declined 17%; net income dropped to $2.0 million, or $0.05 per diluted share, from $12.4 million, or $0.27, a year earlier. Gross margin was 25%, below 32% a year ago but above management's expectations, and the company reaffirmed its full-year gross-margin target at the low- to mid-20% range. Management cited ample HFC inventories and muted demand, while noting a debt-free balance sheet with $35.3 million in cash, 9% year-to-date volume growth, and the extended $210 million DLA contract through July 2031.

Analysis

The key issue is not volume alone but the economics of reclaimed supply: low HFC prices reduce the incentive to recover and process refrigerant, while excess channel inventory delays the scarcity signal implied by the AIM Act. That makes HDSN’s near-term earnings more sensitive to realized price and product mix than to underlying long-run recovery potential. Management’s ability to favor margin over volume offers some protection, but cannot fully offset a prolonged weak-price environment; the reaffirmed 2026 margin range and expectation of flat 2027 pricing imply limited near-term operating leverage.

The policy catalyst is real but uneven. January 2027 California and New York rules may create pockets of reclaimed demand, while a broader HFC supply tightening is a 2029 story. Illegal imports and the lag in EPA inventory data could postpone any price recovery. The DLA relationship can support demand visibility, but its stated contract value should not be treated as equivalent to incremental profit or a guaranteed annual revenue run-rate.

Icorium is strategically interesting, but successful separation technology cuts both ways: improved recovery and lower processing friction could expand Hudson’s addressable volume, yet also increase reclaimed supply and pressure selling prices unless regulatory demand absorbs it. Commercialization, recovery yields, and unit economics—not the partnership announcement—will determine value. Near-term posture: cautious/neutral rather than a structural short; the long-run thesis remains contingent on policy-driven demand outrunning new supply.

Key Decisions for Investors

• Avoid chasing a near-term recovery in HDSN; reassess after the February full-year report for evidence that realized pricing and gross margin are stabilizing without relying on mix changes. A further deterioration in gross margin or renewed price weakness would falsify the stabilization case.
• Treat January 2027 California and New York reclaimed-refrigerant rules as a catalyst to monitor, not yet as an earnings estimate. Verify customer orders, reclaimed volumes, and realized pricing before adding exposure.
• Keep HDSN on a watchlist for a conditional long if subsequent results show services capacity expansion and Icorium commercialization translating into better recovery economics or cash conversion. Verify project milestones, required investment, and processing yields; if recovery volume rises while pricing or margins fall, the technology may expand supply without improving returns.
• Do not assume the DLA award insulates earnings from HFC pricing: track its recognized revenue and contribution alongside working capital and cash generation. Persistent channel inventory, illegal imports, or weak reclaimed-product pricing would argue for continued underweight exposure.